Hyperemesis gravidarum is a severe and potentially life-threatening form of nausea and vomiting during pregnancy, characterized by persistent vomiting, dehydration, electrolyte imbalance, ketonuria, and significant weight loss. It represents the extreme end of the spectrum of pregnancy-related nausea and vomiting and can lead to serious maternal and fetal complications if not managed appropriately. The etiology is multifactorial, involving hormonal, genetic, and psychological components. Early recognition and prompt intervention are essential to prevent adverse outcomes. This case report describes a 26-year-old primigravida presenting with severe hyperemesis gravidarum in early pregnancy. It highlights the clinical presentation, diagnostic workup, therapeutic management, and favorable maternal and fetal outcomes following timely treatment.
Hyperemesis gravidarum is a clinical condition defined by severe, intractable nausea and vomiting during pregnancy that results in dehydration, electrolyte imbalance, ketosis, and weight loss exceeding 5% of pre-pregnancy body weight. It typically manifests during the first trimester, most commonly between 6 and 12 weeks of gestation, and may persist into the second trimester in some patients.
The exact pathophysiology remains incompletely understood, but elevated levels of human chorionic gonadotropin (hCG) and estrogen are considered major contributors. Additional factors such as gastrointestinal dysmotility, genetic susceptibility, and psychosocial influences may also play a role. Unlike normal pregnancy-related nausea, hyperemesis gravidarum is associated with systemic complications including renal dysfunction, hepatic abnormalities, nutritional deficiencies, and neurological complications such as Wernicke’s encephalopathy.
Given its potential severity, early diagnosis and appropriate management are critical to reduce maternal morbidity and ensure optimal fetal outcomes.
Patient History
A 26-year-old primigravida at 9 weeks of gestation presented to the obstetrics department with complaints of persistent nausea and severe vomiting for the past 3 weeks. The vomiting frequency had progressively increased, reaching up to 8–10 episodes per day, and was not relieved by dietary modifications.

The patient reported inability to tolerate oral intake, significant fatigue, dizziness, and decreased urine output. She also noted a weight loss of approximately 4 kilograms over a 2-week period. There was no history of abdominal pain, fever, diarrhea, or urinary symptoms.
Her past medical history was unremarkable, and she had no history of thyroid disease or gastrointestinal disorders. There was no history of similar symptoms in previous pregnancies, as this was her first pregnancy. She was not on any chronic medications.
General Examination
Vital Signs
Abdominal Examination
Differential Diagnosis
The presence of persistent vomiting, dehydration, ketonuria, and significant weight loss strongly suggested hyperemesis gravidarum.
Laboratory Findings

Imaging
Ultrasound Abdomen and Pelvis
Severe hyperemesis gravidarum with dehydration, electrolyte imbalance, and ketosis

Management and Outcome
Treatment Plan
Hospital Admission

Fluid and Electrolyte Management
Pharmacological Therapy
Nutritional Support

After 72 Hours
At 1 Week
At 4 Weeks Follow-Up
Second Trimester
The remainder of the pregnancy was uneventful, and the patient delivered a healthy full-term infant.
Hyperemesis gravidarum is a severe form of pregnancy-related nausea and vomiting that goes beyond typical morning sickness and can lead to significant maternal complications if untreated. It is characterized by persistent vomiting, dehydration, electrolyte imbalance, ketosis, and nutritional deficiencies, affecting multiple organ systems. Due to its severity, it is one of the most common causes of hospitalization in early pregnancy, often requiring intravenous fluids, electrolyte correction, and antiemetic therapy.
The condition also has a notable impact on quality of life, contributing to fatigue, psychological distress, and reduced daily functioning. Its pathophysiology is multifactorial, with hormonal factors such as elevated human chorionic gonadotropin (hCG) and estrogen playing a key role, along with possible genetic and gastrointestinal influences. Early recognition and timely management are essential to prevent complications such as renal dysfunction, Wernicke’s encephalopathy, and adverse fetal outcomes.
Pathophysiology
The pathogenesis is multifactorial:
Risk Factors
Clinical Features
Step 1: Confirmation of Severity
Step 2: Exclusion of Other Causes
Supportive Therapy
Pharmacological Treatment
Nutritional Therapy
Advanced Care
Complications
Maternal
Fetal
Prognosis
Hyperemesis gravidarum is a serious but manageable condition when identified early. This case highlights the importance of recognizing key clinical features such as persistent vomiting, dehydration, and weight loss, followed by appropriate diagnostic evaluation.
Timely intervention with fluid resuscitation, antiemetics, and nutritional support can lead to rapid clinical improvement and prevent complications. A multidisciplinary approach involving obstetricians and physicians is essential to ensure optimal maternal and fetal outcomes.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Hereditary cancer has a rare and underreported cause.
4.
New imaging guidelines for head and neck cancers, a step toward practice change
5.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
1.
Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
Essential Updates in Hematology in Daily Practice
4.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
5.
Importance of Early Detection in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation